Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort pMDI versus Symbicort Turbuhaler and Pulmicort Turbuhaler in adult and adolescent asthma
2007-002734-11Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide in asthma (3 arms), sponsored by AstraZeneca. Primary endpoint: morning peak expiratory flow. Started Jul 2007; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-002734-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002734-11.